Details of the Drug

General Information of Drug (ID: DME8A5R)

• Drug Name: OPS-2071

Indication

Disease Entry	ICD 11	Status	REF
Crohn disease	DD70	Phase 2	[1]

• Drug Type: Small interfering RNA
• Cross-matching ID:
  PubChem CID: 71289877
  TTD ID: D0GNF7

References

• [1] ClinicalTrials.gov (NCT03850509) Efficacy and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation. U.S. National Institutes of Health.